60 Degrees Pharma Announces Approval of Reverse Stock Split Ratio to Maintain Nasdaq Listing

jueves, 15 de enero de 2026, 8:08 am ET1 min de lectura
SXTP--

60 Degrees Pharmaceuticals has announced a 1:4 reverse stock split to comply with Nasdaq listing requirements. The split will become effective on January 20, 2026, and will affect all outstanding shares of common stock. The par value of the stock will remain unchanged at $0.0001 per share, and no fractional shares will be issued. The new CUSIP number for the stock will be 83006G500.

60 Degrees Pharma Announces Approval of Reverse Stock Split Ratio to Maintain Nasdaq Listing

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios